CATX short interest
Perspective Therapeutics Inc. · Healthcare · Medical - Devices · settlement date 2026-09-30
| Shares short | 16,570,625 |
|---|---|
| Change vs prior report | -6,235,666 (-27.3%) |
| Change over six months | +17.3% |
| Days to cover | 5.52 (sector: 3.78) |
| Average daily volume | 3,002,054 |
| Rank in Healthcare | #369 of 922 by days to cover |
CATX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 16,570,625 | -27.3% | 5.52 | 3,002,054 |
| 2026-09-15 | 22,806,291 | -2.3% | 16.85 | 1,353,412 |
| 2026-08-31 | 23,352,203 | +1.4% | 23.64 | 987,921 |
| 2026-08-14 | 23,038,136 | -1.9% | 18.22 | 1,264,403 |
| 2026-07-31 | 23,472,935 | +3.0% | 25.65 | 914,970 |
| 2026-07-15 | 22,783,577 | +0.3% | 10.01 | 2,275,008 |
| 2026-06-30 | 22,724,265 | +66.7% | 7.28 | 3,119,657 |
| 2026-06-15 | 13,633,708 | +6.8% | 8.99 | 1,517,321 |
| 2026-05-29 | 12,763,401 | +1.2% | 11.31 | 1,128,371 |
| 2026-05-15 | 12,615,884 | -2.9% | 7.96 | 1,585,811 |
| 2026-04-30 | 12,997,351 | -4.9% | 8.43 | 1,541,167 |
| 2026-04-15 | 13,672,045 | -3.2% | 17.99 | 759,912 |
| 2026-03-31 | 14,123,380 | +39.9% | 7.26 | 1,945,530 |
| 2026-03-13 | 10,094,062 | +4.7% | 7.83 | 1,289,691 |
| 2026-02-27 | 9,644,608 | +0.3% | 4.53 | 2,128,806 |
| 2026-02-13 | 9,610,826 | +0.7% | 1.97 | 4,882,749 |
| 2026-01-30 | 9,540,242 | +16.2% | 1.01 | 9,490,564 |
| 2026-01-15 | 8,211,185 | -3.9% | 5.33 | 1,539,823 |
| 2025-12-31 | 8,542,582 | +0.0% | 8.08 | 1,057,082 |
| 2025-12-15 | 8,541,741 | +19.4% | 5.01 | 1,705,996 |
| 2025-11-28 | 7,152,424 | +6.4% | 3.59 | 1,994,786 |
| 2025-11-14 | 6,720,024 | +2.1% | 3.31 | 2,029,098 |
| 2025-10-31 | 6,582,745 | +1.4% | 3.66 | 1,799,075 |
| 2025-10-15 | 6,492,938 | -4.2% | 4.73 | 1,371,994 |
| 2025-09-30 | 6,776,377 | +1.6% | 8.24 | 822,278 |
import finzdata as yf
yf.Ticker("CATX").short_interest # every report since 2017
yf.Client().short_interest(["CATX"], start="2018-01-01")Healthcare short interest · CATX price history · Who owns CATX · All short interest